Raleigh Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-85
| Closed | -$3.53K | – | 854 |
|
|
2024
Q4 | $3.53K | Buy |
85
+20
| +31% | +$832 | ﹤0.01% | 757 |
|
|
2024
Q3 | $4.34K | Sell |
65
-91
| -58% | -$6.08K | ﹤0.01% | 715 |
|
|
2024
Q2 | $18.5K | Buy |
156
+40
| +34% | +$4.76K | 0.01% | 441 |
|
|
2024
Q1 | $12.4K | Buy |
116
+81
| +231% | +$8.63K | 0.01% | 521 |
|
|
2023
Q4 | $3.48K | Buy |
+35
| New | +$3.48K | ﹤0.01% | 802 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | -$1K | – | 652 |
|
|
2021
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 292 |
|